Orient Pharma Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 412.012 million compared to TWD 353.539 million a year ago. Operating loss was TWD 166.754 million compared to TWD 205.367 million a year ago. Net loss was TWD 171.376 million compared to TWD 201.027 million a year ago. Basic loss per share was TWD 1.01 compared to TWD 1.29 a year ago.